PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 35,975 Shares of Stock

Posted by Jeff Wilder on Oct 7th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 35,975 shares of the company’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75. Following the completion of the sale, the chief executive officer directly owned 54,435,966 shares of the company’s stock, valued at $2,345,645,774.94. The trade was a 0.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.
On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total value of $1,033,395.84.
On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total value of $1,107,470.52.
On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The shares were sold at an average price of $41.13, for a total value of $1,358,606.16.
On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The stock was sold at an average price of $45.03, for a total value of $14,274.51.
On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total transaction of $476,226.67.
On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total transaction of $396,098.36.
On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total transaction of $1,046,238.93.
On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total transaction of $984,943.68.

PACS Group Stock Performance

PACS traded up $0.21 during trading on Wednesday, reaching $43.02. The company’s stock had a trading volume of 673,130 shares, compared to its average volume of 899,083. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The company’s fifty day moving average price is $43.81 and its 200-day moving average price is $39.81. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49. The company has a market capitalization of $6.81 billion, a price-to-earnings ratio of 25.01, a price-to-earnings-growth ratio of 1.33 and a beta of -0.08.

PACS Group (NYSE:PACS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. On average, equities analysts forecast that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. UBS Group boosted their price target on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Royal Bank Of Canada boosted their target price on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Wall Street Zen cut PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. JPMorgan Chase & Co. lifted their price target on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Finally, Oppenheimer boosted their price objective on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $58.80.

Get Our Latest Stock Analysis on PACS

Institutional Investors Weigh In On PACS Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its position in PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares in the last quarter. 8 Knots Management LLC purchased a new stake in shares of PACS Group in the fourth quarter valued at $23,421,000. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of PACS Group in the first quarter valued at $6,762,000. Bank of New York Mellon Corp acquired a new stake in shares of PACS Group during the second quarter valued at $8,196,000. Finally, Principal Financial Group Inc. acquired a new stake in shares of PACS Group during the first quarter valued at $3,171,000.

About PACS Group

(Get Free Report)

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.